Finland· FI-REL-REL2134

Fiberform

A weizen - weizenfasern product containing testa triticum tricum purificata (lat.), registered in Finland by Tricum Ab.

ATC A06AC07

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedFiberformATCA06AC07REGISTER NO.FI-REL-REL2134PACKS LISTED0CHECKEDSeptember 27, 2026

The record

At a glance

Fimea (Finland)
Active substance
Testa triticum tricum purificata (lat.)
Manufacturer
Tricum Ab
Country
Finland (FI)
ATC code
A06AC07
ATC class
Weizen - Weizenfasern
Defined daily dose
10 g, O
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under A06AC07

Weizen - weizenfasern, as other registers publish it.

All weizen - weizenfasern products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5871720d-21f4-4317-a21c-b6e8a802159b
GET /v1/drugs/5871720d-21f4-4317-a21c-b6e8a802159b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "10",
  "form": "rakeet",
  "route": null,
  "ddd_unit": "g",
  "strength": null,
  "atc_label": "vehnäkuitu",
  "ma_number": "9495",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL2134",
  "authorised_at": "1987-06-10"
}

See everything about weizen - weizenfasern.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.